Gene therapy approaches for modulating bone regeneration.

[1]  Richard A.F. Clark,et al.  The Molecular and Cellular Biology of Wound Repair , 2012, Springer US.

[2]  T A Einhorn,et al.  Growth Factor Regulation of Fracture Repair , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  H. Uludaǧ,et al.  Carrier systems for bone morphogenetic proteins. , 1999, Clinical orthopaedics and related research.

[4]  H. Uludaǧ,et al.  Establishing an Immortalized Human Osteoprecursor Cell Line: OPC1 , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  J. Hollinger,et al.  Reconstruction of bone using calcium phosphate bone cements: a critical review. , 1999, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[6]  J. Wozney,et al.  Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. , 1999, Journal of biomedical materials research.

[7]  Jeffrey Bonadio,et al.  Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration , 1999, Nature Medicine.

[8]  M. Imperiale,et al.  Immortalized cementoblasts and periodontal ligament cells in culture. , 1999, Bone.

[9]  S. Bulstra,et al.  Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect , 1999 .

[10]  W. Holzgreve,et al.  In utero hematopoietic stem cell transfer: current status and future strategies. , 1999, European journal of obstetrics, gynecology, and reproductive biology.

[11]  A Daluiski,et al.  The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. , 1999, The Journal of bone and joint surgery. American volume.

[12]  J O Hollinger,et al.  Tissue-engineered bone biomimetic to regenerate calvarial critical-sized defects in athymic rats. , 1999, Journal of biomedical materials research.

[13]  J. Wozney,et al.  rhBMP‐Collagen Sponges as Osteoinductive Devices: Effects of in Vitro Sponge Characteristics and Protein pI on in Vivo rhBMP Pharmacokinetics , 1999, Annals of the New York Academy of Sciences.

[14]  J. Hollinger,et al.  Tissue Engineering of Bone in the Craniofacial Complex , 1999, Annals of the New York Academy of Sciences.

[15]  David J. Mooney,et al.  DNA delivery from polymer matrices for tissue engineering , 1999, Nature Biotechnology.

[16]  G. Mundy,et al.  Systemic Administration of Acidic Fibroblast Growth Factor (FGF‐1) Prevents Bone Loss and Increases New Bone Formation in Ovariectomized Rats , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  D. Bates,et al.  Vascular Endothelial Growth Factor and Microvascular Permeability , 1999, Microcirculation.

[18]  M. Longaker,et al.  Gene expression of insulin-like growth factors I and II in rat membranous osteotomy healing. , 1999, Annals of Plastic Surgery.

[19]  D. Solter,et al.  Putting Stem Cells to Work , 1999, Science.

[20]  J. Schmitt,et al.  Bone morphogenetic proteins: An update on basic biology and clinical relevance , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[21]  N. Sarvetnick,et al.  Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. , 1998, Human gene therapy.

[22]  J. Trempe,et al.  Optimization of packaging of adeno-associated virus gene therapy vectors using plasmid transfections. , 1998, Journal of virological methods.

[23]  Kozo Nakamura,et al.  Single local injection of recombinant fibroblast growth factor‐2 stimulates healing of segmental bone defects in rabbits , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[24]  K. Naresh,et al.  Preclinical studies on suicide gene therapy for head/neck cancer: a novel method for evaluation of treatment efficacy. , 1998, Anticancer research.

[25]  R. Dummer,et al.  The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. , 1998, Human gene therapy.

[26]  R J O'Keefe,et al.  The potential role of transforming growth factor beta in fracture healing. , 1998, Clinical orthopaedics and related research.

[27]  M. Bostrom,et al.  Expression of bone morphogenetic proteins in fracture healing. , 1998, Clinical orthopaedics and related research.

[28]  D. Brough,et al.  The Coxsackievirus-Adenovirus Receptor Protein Can Function as a Cellular Attachment Protein for Adenovirus Serotypes from Subgroups A, C, D, E, and F , 1998, Journal of Virology.

[29]  M. Bostrom,et al.  Transforming growth factor beta in fracture repair. , 1998, Clinical orthopaedics and related research.

[30]  S. Trippel.  Potential role of insulinlike growth factors in fracture healing. , 1998, Clinical orthopaedics and related research.

[31]  S. Goldstein,et al.  Gene therapy for tissue repair and regeneration. , 1998, Advanced drug delivery reviews.

[32]  V. Goldberg,et al.  The Effect of Implants Loaded with Autologous Mesenchymal Stem Cells on the Healing of Canine Segmental Bone Defects* , 1998, The Journal of bone and joint surgery. American volume.

[33]  J. Verhaagen,et al.  Viral vectors, tools for gene transfer in the nervous system , 1998, Progress in Neurobiology.

[34]  B. O'Connell,et al.  The mouth is a gateway to the body: gene therapy in 21st-century dental practice. , 1998, Journal of the California Dental Association.

[35]  T. Sakou.  Bone morphogenetic proteins: from basic studies to clinical approaches. , 1998, Bone.

[36]  Hiroshi Fukuda,et al.  Recombinant Human Basic Fibroblast Growth Factor Accelerates Fracture Healing by Enhancing Callus Remodeling in Experimental Dog Tibial Fracture , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  P. ten Dijke,et al.  Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. , 1998, Bone.

[38]  Hollinger,et al.  Sustained release emphasizing recombinant human bone morphogenetic protein-2. , 1998, Advanced drug delivery reviews.

[39]  G. Finerman,et al.  Regional gene therapy with a BMP‐2‐producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[40]  E. Shillitoe.  Gene therapy for oral cancer: recent progress in research. , 1998, Oral oncology.

[41]  W. Hayes,et al.  Bone regeneration by implantation of purified, culture‐expanded human mesenchymal stem cells , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[42]  A. Beaudet,et al.  Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity , 1998, Nature Genetics.

[43]  J. Hollinger,et al.  Macrophysiologic Roles of a Delivery System for Vulnerary Factors Needed for Bone Regeneration , 1997, Annals of the New York Academy of Sciences.

[44]  J. Wozney,et al.  Bone Formation with Use of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2)* , 1997, The Journal of bone and joint surgery. American volume.

[45]  W. Westra,et al.  Safety of in vivo adenovirus-mediated thymidine kinase treatment of oral cancer. , 1997, Archives of otolaryngology--head & neck surgery.

[46]  C. Harding,et al.  CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity , 1997, The Journal of experimental medicine.

[47]  D. Peterson,et al.  Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors , 1997, Nature Genetics.

[48]  L. Duan,et al.  Optimizing Suicide Gene Therapy for Head and Neck Cancer , 1997, The Laryngoscope.

[49]  G. Weiner,et al.  Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[50]  F. Gage,et al.  Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[51]  L Naldini,et al.  Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector , 1997, Journal of virology.

[52]  J. Wolff.  Naked DNA transport and expression in mammalian cells , 1997, Neuromuscular Disorders.

[53]  S. Kadiyala,et al.  Culture-expanded, bone marrow-derived mesenchymal stem cells can regenerate a critical-sized segmental bone defect , 1997 .

[54]  P. Felgner.  Nonviral strategies for gene therapy. , 1997, Scientific American.

[55]  S. Davis,et al.  Biomedical applications of nanotechnology--implications for drug targeting and gene therapy. , 1997, Trends in biotechnology.

[56]  J. Fiorellini,et al.  A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. , 1997, The International journal of periodontics & restorative dentistry.

[57]  Donald E. Chickering,et al.  Biologically erodable microspheres as potential oral drug delivery systems , 1997, Nature.

[58]  M. Urist,et al.  Bone Morphogenetic Protein: The Molecularization of Skeletal System Development , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[59]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[60]  H. Oonishi,et al.  Particulate Bioglass Compared With Hydroxyapatite as a Bone Graft Substitute , 1997, Clinical orthopaedics and related research.

[61]  K. Culver.  Gene Therapy: A Primer for Physicians , 1996, Annals of Internal Medicine.

[62]  J. Hollinger,et al.  The integrated processes of hard tissue regeneration with special emphasis on fracture healing. , 1996, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[63]  M. Rudnicki,et al.  A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[64]  B. Baum,et al.  Evidence for the systemic delivery of a transgene product from salivary glands. , 1996, Human gene therapy.

[65]  V. Rosen,et al.  The effects of aging on the bone inductive activity of recombinant human bone morphogenetic protein-2. , 1996, Endocrinology.

[66]  E. Poeschla,et al.  Development of HIV vectors for anti-HIV gene therapy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[67]  R. Balice-Gordon,et al.  In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. , 1996, Human gene therapy.

[68]  Takayuki Asahara,et al.  Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb , 1996, The Lancet.

[69]  J. Wozney,et al.  Maxillary alveolar cleft repair in dogs using recombinant human bone morphogenetic protein-2 and a polymer carrier. , 1996, Plastic and reconstructive surgery.

[70]  R. Coutts,et al.  Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Growth Factors as Therapeutic Agents*† , 1996 .

[71]  E. Raz,et al.  Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization , 1996, Science.

[72]  M. Uusitupa,et al.  Does lactose intolerance predispose to low bone density? A population-based study of perimenopausal Finnish women. , 1996, Bone.

[73]  W. Giannobile,et al.  Periodontal tissue engineering by growth factors. , 1996, Bone.

[74]  S. Goldstein,et al.  Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[75]  J M Neigel,et al.  Use of Demineralized Bone Implants in Orbital and Craniofacial Reconstruction and a Review of the Literature , 1996, Ophthalmic plastic and reconstructive surgery.

[76]  J. Leiden,et al.  Immune responses to transgene–encoded proteins limit the stability of gene expression after injection of replication–defective adenovirus vectors , 1996, Nature Medicine.

[77]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[78]  T. Barka,et al.  Retrovirus-mediated gene transfer into salivary glands in vivo. , 1996, Human gene therapy.

[79]  J O Hollinger,et al.  Role of bone substitutes. , 1996, Clinical orthopaedics and related research.

[80]  G. Widera,et al.  Particle-mediated nucleic acid immunization. , 1996, Journal of biotechnology.

[81]  Ronald G. Crystal,et al.  Transfer of Genes to Humans: Early Lessons and Obstacles to Success , 1995, Science.

[82]  L. Spångberg,et al.  Transdentinal stimulation of reparative dentine formation by osteogenic protein-1 in monkeys. , 1995, Archives of oral biology.

[83]  T A Einhorn,et al.  Enhancement of fracture-healing. , 1995, The Journal of bone and joint surgery. American volume.

[84]  S. Parker,et al.  Cancer gene therapy using plasmid DNA: safety evaluation in rodents and non-human primates. , 1995, Human gene therapy.

[85]  S. Parker,et al.  Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. , 1995, Human gene therapy.

[86]  M. Marquet,et al.  Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials. , 1995, Human gene therapy.

[87]  H. Ertl,et al.  Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses , 1995, Journal of virology.

[88]  M. Kohno,et al.  Distribution and Characterization of Specific Cellular Binding Proteins for Bone Morphogenetic Protein-2 (*) , 1995, The Journal of Biological Chemistry.

[89]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[90]  S. Lynch,et al.  Comparison of canine and non-human primate animal models for periodontal regenerative therapy: results following a single administration of PDGF/IGF-I. , 1994, Journal of periodontology.

[91]  J. Sprent,et al.  Lymphocyte activation , 1994, Journal of cellular biochemistry.

[92]  V. Rosen,et al.  Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[93]  G. Nemerow,et al.  Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization , 1994, The Journal of cell biology.

[94]  M. Nakashima.  Induction of Dentin Formation on Canine Amputated Pulp by Recombinant Human Bone Morphogenetic Proteins (BMP)-2 and -4 , 1994, Journal of dental research.

[95]  J. Lazo,et al.  Cationic Liposomes for Direct Gene Transfer in Therapy of Cancer and Other Diseases a , 1994, Annals of the New York Academy of Sciences.

[96]  N A Peppas,et al.  New challenges in biomaterials. , 1994, Science.

[97]  J. Wozney,et al.  Transforming Growth Factor-β Gene Family Members and Bone* , 1994 .

[98]  G. Mundy.  Cytokines and growth factors in the regulation of bone remodeling , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[99]  E. Wang,et al.  Bone morphogenetic proteins (BMPs): therapeutic potential in healing bony defects. , 1993, Trends in biotechnology.

[100]  H R Allcock,et al.  Use of polyphosphazenes for skeletal tissue regeneration. , 1993, Journal of biomedical materials research.

[101]  J. Hollinger.  Factors for osseous repair and delivery: Part II. , 1993, The Journal of craniofacial surgery.

[102]  R. Lindsay,et al.  Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol. , 1993, The Journal of clinical investigation.

[103]  G. Nemerow,et al.  Integrins α v β 3 and α v β 5 promote adenovirus internalization but not virus attachment , 1993, Cell.

[104]  R. Recker,et al.  The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats. , 1993, Endocrinology.

[105]  MacNeil Rl,et al.  Development of the murine periodontium. I. Role of basement membrane in formation of a mineralized tissue on the developing root dentin surface. , 1993 .

[106]  R. Naviaux,et al.  Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[107]  A. Reddi,et al.  Regulation of cartilage and bone differentiation by bone morphogenetic proteins. , 1992, Current opinion in cell biology.

[108]  T. Einhorn,et al.  i) The biochemistry of fracture healing , 1992 .

[109]  A. Gown,et al.  Production of a monoclonal antibody to an attachment protein derived from human cementum , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[110]  R. Page,et al.  Isolation of human tumor cells that produce cementum proteins in culture. , 1992, Bone and mineral.

[111]  V. Rosen,et al.  The BMP proteins in bone formation and repair. , 1992, Trends in genetics : TIG.

[112]  J. Leiden,et al.  Systemic delivery of recombinant proteins by genetically modified myoblasts. , 1991, Science.

[113]  M. Malim,et al.  Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes , 1991, The Journal of experimental medicine.

[114]  W. Enneking,et al.  Observations on massive retrieved human allografts. , 1991, The Journal of bone and joint surgery. American volume.

[115]  M S Reddy,et al.  The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. , 1991, Journal of periodontology.

[116]  S. Goldring,et al.  Skeletal tissue response to cytokines. , 1990, Clinical orthopaedics and related research.

[117]  D. Kalu,et al.  Human parathyroid hormone‐(1‐34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[118]  P. Libby,et al.  Implantation of vascular grafts lined with genetically modified endothelial cells. , 1989, Science.

[119]  F. Gage,et al.  Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression. , 1988, Science.

[120]  V. Rosen,et al.  Purification and characterization of other distinct bone-inducing factors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[121]  R. Holmes,et al.  Porous hydroxyapatite as a bone graft substitute in alveolar ridge augmentation: a histometric study. , 1987, International journal of oral and maxillofacial surgery.

[122]  Y. Barrandon,et al.  Expression of an exogenous growth hormone gene by transplantable human epidermal cells. , 1987, Science.

[123]  R. Crystal,et al.  Clonal gene therapy: transplanted mouse fibroblast clones express human alpha 1-antitrypsin gene in vivo. , 1987, Science.

[124]  T. Palmer,et al.  Efficient retrovirus-mediated transfer and expression of a human adenosine deaminase gene in diploid skin fibroblasts from an adenosine deaminase-deficient human. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[125]  J. Rodrigo,et al.  Contemporary Bone Graft Physiology and Surgery , 1985, Clinical orthopaedics and related research.

[126]  Harakas Nk.  Demineralized bone-matrix-induced osteogenesis. , 1984 .

[127]  L. Fleming,et al.  Open fractures of the tibia treated with the Lottes nail. , 1983, The Journal of bone and joint surgery. American volume.

[128]  Michael Jarcho,et al.  Calcium phosphate ceramics as hard tissue prosthetics. , 1981, Clinical orthopaedics and related research.

[129]  J. Hartley,et al.  Naturally occurring murine leukemia viruses in wild mice: characterization of a new "amphotropic" class , 1976, Journal of virology.

[130]  Jay A. Levy.  Xenotropic Viruses: Murine Leukemia Viruses Associated with NIH Swiss, NZB, and Other Mouse Strains , 1973, Science.

[131]  C. Gregory.  The Current Status of Bone and Joint Transplants , 1972, Clinical orthopaedics and related research.

[132]  Ottolenghi Ce.  Massive osteo and osteo-articular bone grafts. Technic and results of 62 cases. , 1972 .

[133]  R. Rutherford.  CHAPTER 60 – REGENERATION OF DENTIN , 2000 .

[134]  T. Hollon.  Researchers and regulators reflect on first gene therapy death , 2000, Nature Medicine.

[135]  J. Wataha,et al.  Cloned 3T6 cell line from CD-1 mouse fetal molar dental papillae. , 1998, Connective tissue research.

[136]  J. Wozney.  The bone morphogenetic protein family: multifunctional cellular regulators in the embryo and adult. , 1998, European journal of oral sciences.

[137]  R. Coutts,et al.  Growth factors as therapeutic agents. , 1997, Instructional course lectures.

[138]  Lajos Pusztai,et al.  Cell proliferation in cancer : regulatory mechanisms of neoplastic cell growth , 1996 .

[139]  C. Bünger,et al.  Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells. , 1996, Bone.

[140]  W C Hayes,et al.  Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. , 1996, Biomaterials.

[141]  D. L. Sokol,et al.  Gene therapy: basic concepts and recent advances. , 1996, Critical reviews in eukaryotic gene expression.

[142]  K. Leong,et al.  Poly(α-hydroxy acids). Carriers for bone morphogenetic proteins , 1996 .

[143]  John P. Bilezikian,et al.  Principles of Bone Biology , 1996 .

[144]  Jeffrey O. Hollinger,et al.  Biomedical applications of synthetic biodegradable polymers , 1995 .

[145]  P. Christou.  Chapter 27 Particle Bombardment , 1995 .

[146]  S. Pitaru,et al.  Cementum specific components which influence periodontal connective tissue cells. , 1995, Connective tissue research.

[147]  M. Fitzgerald,et al.  A new biological approach to vital pulp therapy. , 1995, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[148]  Gary E. Friedlaender,et al.  Bone formation and repair , 1994 .

[149]  D. Kingsley,et al.  What do BMPs do in mammals? Clues from the mouse short-ear mutation. , 1994, Trends in genetics : TIG.

[150]  L. Teerenhovi.  Primary gastrointestinal lymphomas. , 1993, Annales chirurgiae et gynaecologiae.

[151]  E. Wang,et al.  Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. , 1993, Growth factors.

[152]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[153]  Lindholm Ts,et al.  Functional carriers for bone morphogenetic proteins. , 1993 .

[154]  J. Hollinger,et al.  Bone Regeneration Materials for the Mandibular and Craniofacial Complex , 1992 .

[155]  H. Slavkin,et al.  Hertwig's epithelial root sheath differentiation and initial cementum and bone formation during long-term organ culture of mouse mandibular first molars using serumless, chemically-defined medium. , 1989, Journal of periodontal research.

[156]  A. Reddi,et al.  Extracellular matrix biochemistry , 1984 .

[157]  J. McCubrey,et al.  Endogenous mouse leukemia viruses. , 1983, Annual review of genetics.